Reckitt launch­es ini­tia­tive to iden­ti­fy peo­ple with un­di­ag­nosed chron­ic lung dis­ease

3 years ago
Pharma
Marketing

Ha­le­on ups full-year guid­ance af­ter rocky spin­off from GSK

3 years ago
Pharma

Te­va wins $175M set­tle­ment af­ter ju­ry or­ders Eli Lil­ly to pay up on patent in­fringe­ment suit

3 years ago
Pharma
Law

EMA signs off on Sanofi and GSK's BAR­DA-fund­ed Covid boost­er shot

3 years ago
Coronavirus

Cy­cla­cel pulls the plug on Dai­ichi-part­nered chemo — 8 years af­ter a failed PhI­II in AML

3 years ago
Pharma

CG On­col­o­gy spot­lights on­colyt­ic virus com­bo da­ta ahead of full read­out due next year

3 years ago
R&D

Klick Health fills out glob­al team lead­er­ship roles, con­tin­ues push on ‘reimag­ined’ agency mod­el

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: Al­ca­mi ac­quired by cap­i­tal groups; Wheel­er Bio starts on new man­u­fac­tur­ing site in Ok­la­homa

3 years ago
Manufacturing

In 'mirac­u­lous' case, doc­tors treat­ed a ba­by with a rare ge­net­ic dis­ease be­fore she was born

3 years ago
R&D
Discovery

Af­ter rare pub­lic brush­back, FDA again turns away Brain­Stor­m's ALS drug with RTF let­ter

3 years ago
R&D
FDA+

Bio­haven claims $300M+ pub­lic of­fer­ing as com­pa­ny charts new jour­ney af­ter Pfiz­er buy­out

3 years ago
Financing

Growth in cell ther­a­py clin­i­cal pro­grams means Charles Riv­er boosts of­fer­ings in Mem­phis

3 years ago
Manufacturing

Oral al­ter­na­tive to eye in­jec­tions? No­vo backs start­up’s big plan to re­pur­pose shelved drug

3 years ago
Financing
Startups

Form 483 cites Lupin man­u­fac­tur­ing site in In­dia for con­t­a­m­i­na­tion and oth­er qual­i­ty con­trol ob­ser­va­tions

3 years ago
R&D
Pharma

Vi­a­tris lands a court win over As­traZeneca, but gener­ics for block­buster in­haler still not ready to launch

3 years ago
Pharma

In wan­ing Covid mar­ket, MiNK un­veils da­ta on nat­ur­al killer T cell ther­a­py for ARDS, pend­ing con­tract with DARPA

3 years ago
R&D
Coronavirus

Bio­gen se­lects new CEO: for­mer Sanofi head Chris Viehbach­er

3 years ago
People

Fresh out of Flag­ship, David Ep­stein takes the helm at Seagen months af­ter Clay Sie­gall re­signed

3 years ago
People

EQRx's pric­ing re­form mod­el on life sup­port as ex­ecs shed PD-L1 plans in US for lung can­cer

3 years ago
R&D

Trio of biotechs trim their pipelines as rough mar­ket not let­ting up in third quar­ter

3 years ago
R&D

A can­cer drug un­der clin­i­cal hold, an mR­NA ther­a­py, a kid­ney med: As­traZeneca punts three ear­ly-stage pro­grams

3 years ago
R&D

FDA ad­comm votes nar­row­ly against Veru's Covid drug, cit­ing un­cer­tain­ties amid mor­tal­i­ty ben­e­fit in small tri­al

3 years ago
R&D
FDA+

Pfiz­er faces la­bor ac­tion in Aus­tralia as work­ers protest wage in­crease at man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Pharma
Manufacturing

Gener­ic drug in­dus­try push­es FDA to ad­dress ni­trosamine im­pu­ri­ties in a new way

3 years ago
Manufacturing
First page Previous page 430431432433434435436 Next page Last page
A service from the Financial Times